Allurion Technologies, Inc.
ALUR Healthcare Medical Devices
Allurion Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $15.2 million, down 52.6% from fiscal 2024.
- Revenue
- −47.2%
- EPS
- −46.5%
- Free cash flow
- +66.0%
Quarter to March 2026, against a year earlier
Follow ALUR
Alert me
Allurion Technologies, Inc. (ALUR) EV/Sales
As of 6 November 2026, Allurion Technologies, Inc. (ALUR) trades at a EV/Sales of 5.3×. Over the past ten years it has ranged from 0.0× (March 2023) to 6.3× (May 2026); the current reading is higher than 90% of that period. That is above the Medical Devices industry median of 2.8× and above the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 4.9× | 89.64% |
| FY2024 | 2.6× | (4.90%) |
| FY2023 | 2.7× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Mar 2026 | 6.0× | 21.05% |
| Dec 2025 | 4.9× | 4.74% |
| Sep 2025 | 4.7× | 28.84% |
| Jun 2025 | 3.7× | 59.41% |
| 12 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NNOX Nano-X Imaging Ltd. compare | −0.5× |
| RBOT Vicarious Surgical Inc. compare | n/m |
| ARAY Accuray Incorporated compare | 0.2× |
| SNWV Sanuwave Health Inc. compare | 0.7× |
| CTSO Cytosorbents Corporation compare | 0.7× |
| LFWD Lifeward Ltd. compare | 0.8× |
| PMI Flag Ship Acquisition Corp compare | 2.8× |
| ALUR Allurion Technologies, Inc. | 5.3× |
| HSCS HeartSciences Inc. compare | 519× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)